According to our LPI (LP Information) latest study, the global Biobanking market size was valued at US$ 2871.2 million in 2023. With growing demand in downstream market, the Biobanking is forecast to a readjusted size of US$ 4658.3 million by 2030 with a CAGR of 7.2% during review period.
The research report highlights the growth potential of the global Biobanking market. Biobanking are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Biobanking. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Biobanking market.
Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.
Global Biobanking key players include Thermo Fisher, Beckman Coulter, Panasonic, etc. Global top three manufacturers hold a share over 15%.
United States is the largest market, with a share over 40%, followed by China, and Europe, both have a share about 50 percent.
In terms of product, Consumable is the largest segment, with a share about 55%. And in terms of application, the largest application is Population Biobanks, followed by Tissue Biobanks, Virtual Biobanks, etc.
Key Features:
The report on Biobanking market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Biobanking market. It may include historical data, market segmentation by Type (e.g., Equipment, Consumable), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Biobanking market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Biobanking market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Biobanking industry. This include advancements in Biobanking technology, Biobanking new entrants, Biobanking new investment, and other innovations that are shaping the future of Biobanking.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Biobanking market. It includes factors influencing customer ' purchasing decisions, preferences for Biobanking product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Biobanking market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Biobanking market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Biobanking market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Biobanking industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Biobanking market.
Market Segmentation:
Biobanking market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Equipment
Consumable
Segmentation by application
Virtual Biobanks
Tissue Biobanks
Population Biobanks
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher
Beckman Coulter
Panasonic
SOL Group
Promega
Merck
Greiner Bio One
Chart Industries
Brooks Life Science
Tecan Group
QIAGEN
BD
Lifeline Scientific
Hamilton
So-Low
TTP Labtech Ltd
Biolife Solutions
DNA Genotek
Custom Biogenic Systems
LVL Technologies
BioRep

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Biobanking Market Size 2019-2030 2.1.2 Biobanking Market Size CAGR by Region 2019 VS 2023 VS 2030 2.2 Biobanking Segment by Type 2.2.1 Equipment 2.2.2 Consumable 2.3 Biobanking Market Size by Type 2.3.1 Biobanking Market Size CAGR by Type (2019 VS 2023 VS 2030) 2.3.2 Global Biobanking Market Size Market Share by Type (2019-2024) 2.4 Biobanking Segment by Application 2.4.1 Virtual Biobanks 2.4.2 Tissue Biobanks 2.4.3 Population Biobanks 2.5 Biobanking Market Size by Application 2.5.1 Biobanking Market Size CAGR by Application (2019 VS 2023 VS 2030) 2.5.2 Global Biobanking Market Size Market Share by Application (2019-2024) 3 Biobanking Market Size by Player 3.1 Biobanking Market Size Market Share by Players 3.1.1 Global Biobanking Revenue by Players (2019-2024) 3.1.2 Global Biobanking Revenue Market Share by Players (2019-2024) 3.2 Global Biobanking Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Biobanking by Regions 4.1 Biobanking Market Size by Regions (2019-2024) 4.2 Americas Biobanking Market Size Growth (2019-2024) 4.3 APAC Biobanking Market Size Growth (2019-2024) 4.4 Europe Biobanking Market Size Growth (2019-2024) 4.5 Middle East & Africa Biobanking Market Size Growth (2019-2024) 5 Americas 5.1 Americas Biobanking Market Size by Country (2019-2024) 5.2 Americas Biobanking Market Size by Type (2019-2024) 5.3 Americas Biobanking Market Size by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Biobanking Market Size by Region (2019-2024) 6.2 APAC Biobanking Market Size by Type (2019-2024) 6.3 APAC Biobanking Market Size by Application (2019-2024) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Biobanking by Country (2019-2024) 7.2 Europe Biobanking Market Size by Type (2019-2024) 7.3 Europe Biobanking Market Size by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Biobanking by Region (2019-2024) 8.2 Middle East & Africa Biobanking Market Size by Type (2019-2024) 8.3 Middle East & Africa Biobanking Market Size by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Biobanking Market Forecast 10.1 Global Biobanking Forecast by Regions (2025-2030) 10.1.1 Global Biobanking Forecast by Regions (2025-2030) 10.1.2 Americas Biobanking Forecast 10.1.3 APAC Biobanking Forecast 10.1.4 Europe Biobanking Forecast 10.1.5 Middle East & Africa Biobanking Forecast 10.2 Americas Biobanking Forecast by Country (2025-2030) 10.2.1 United States Biobanking Market Forecast 10.2.2 Canada Biobanking Market Forecast 10.2.3 Mexico Biobanking Market Forecast 10.2.4 Brazil Biobanking Market Forecast 10.3 APAC Biobanking Forecast by Region (2025-2030) 10.3.1 China Biobanking Market Forecast 10.3.2 Japan Biobanking Market Forecast 10.3.3 Korea Biobanking Market Forecast 10.3.4 Southeast Asia Biobanking Market Forecast 10.3.5 India Biobanking Market Forecast 10.3.6 Australia Biobanking Market Forecast 10.4 Europe Biobanking Forecast by Country (2025-2030) 10.4.1 Germany Biobanking Market Forecast 10.4.2 France Biobanking Market Forecast 10.4.3 UK Biobanking Market Forecast 10.4.4 Italy Biobanking Market Forecast 10.4.5 Russia Biobanking Market Forecast 10.5 Middle East & Africa Biobanking Forecast by Region (2025-2030) 10.5.1 Egypt Biobanking Market Forecast 10.5.2 South Africa Biobanking Market Forecast 10.5.3 Israel Biobanking Market Forecast 10.5.4 Turkey Biobanking Market Forecast 10.5.5 GCC Countries Biobanking Market Forecast 10.6 Global Biobanking Forecast by Type (2025-2030) 10.7 Global Biobanking Forecast by Application (2025-2030) 11 Key Players Analysis 11.1 Thermo Fisher 11.1.1 Thermo Fisher Company Information 11.1.2 Thermo Fisher Biobanking Product Offered 11.1.3 Thermo Fisher Biobanking Revenue, Gross Margin and Market Share (2019-2024) 11.1.4 Thermo Fisher Main Business Overview 11.1.5 Thermo Fisher Latest Developments 11.2 Beckman Coulter 11.2.1 Beckman Coulter Company Information 11.2.2 Beckman Coulter Biobanking Product Offered 11.2.3 Beckman Coulter Biobanking Revenue, Gross Margin and Market Share (2019-2024) 11.2.4 Beckman Coulter Main Business Overview 11.2.5 Beckman Coulter Latest Developments 11.3 Panasonic 11.3.1 Panasonic Company Information 11.3.2 Panasonic Biobanking Product Offered 11.3.3 Panasonic Biobanking Revenue, Gross Margin and Market Share (2019-2024) 11.3.4 Panasonic Main Business Overview 11.3.5 Panasonic Latest Developments 11.4 SOL Group 11.4.1 SOL Group Company Information 11.4.2 SOL Group Biobanking Product Offered 11.4.3 SOL Group Biobanking Revenue, Gross Margin and Market Share (2019-2024) 11.4.4 SOL Group Main Business Overview 11.4.5 SOL Group Latest Developments 11.5 Promega 11.5.1 Promega Company Information 11.5.2 Promega Biobanking Product Offered 11.5.3 Promega Biobanking Revenue, Gross Margin and Market Share (2019-2024) 11.5.4 Promega Main Business Overview 11.5.5 Promega Latest Developments 11.6 Merck 11.6.1 Merck Company Information 11.6.2 Merck Biobanking Product Offered 11.6.3 Merck Biobanking Revenue, Gross Margin and Market Share (2019-2024) 11.6.4 Merck Main Business Overview 11.6.5 Merck Latest Developments 11.7 Greiner Bio One 11.7.1 Greiner Bio One Company Information 11.7.2 Greiner Bio One Biobanking Product Offered 11.7.3 Greiner Bio One Biobanking Revenue, Gross Margin and Market Share (2019-2024) 11.7.4 Greiner Bio One Main Business Overview 11.7.5 Greiner Bio One Latest Developments 11.8 Chart Industries 11.8.1 Chart Industries Company Information 11.8.2 Chart Industries Biobanking Product Offered 11.8.3 Chart Industries Biobanking Revenue, Gross Margin and Market Share (2019-2024) 11.8.4 Chart Industries Main Business Overview 11.8.5 Chart Industries Latest Developments 11.9 Brooks Life Science 11.9.1 Brooks Life Science Company Information 11.9.2 Brooks Life Science Biobanking Product Offered 11.9.3 Brooks Life Science Biobanking Revenue, Gross Margin and Market Share (2019-2024) 11.9.4 Brooks Life Science Main Business Overview 11.9.5 Brooks Life Science Latest Developments 11.10 Tecan Group 11.10.1 Tecan Group Company Information 11.10.2 Tecan Group Biobanking Product Offered 11.10.3 Tecan Group Biobanking Revenue, Gross Margin and Market Share (2019-2024) 11.10.4 Tecan Group Main Business Overview 11.10.5 Tecan Group Latest Developments 11.11 QIAGEN 11.11.1 QIAGEN Company Information 11.11.2 QIAGEN Biobanking Product Offered 11.11.3 QIAGEN Biobanking Revenue, Gross Margin and Market Share (2019-2024) 11.11.4 QIAGEN Main Business Overview 11.11.5 QIAGEN Latest Developments 11.12 BD 11.12.1 BD Company Information 11.12.2 BD Biobanking Product Offered 11.12.3 BD Biobanking Revenue, Gross Margin and Market Share (2019-2024) 11.12.4 BD Main Business Overview 11.12.5 BD Latest Developments 11.13 Lifeline Scientific 11.13.1 Lifeline Scientific Company Information 11.13.2 Lifeline Scientific Biobanking Product Offered 11.13.3 Lifeline Scientific Biobanking Revenue, Gross Margin and Market Share (2019-2024) 11.13.4 Lifeline Scientific Main Business Overview 11.13.5 Lifeline Scientific Latest Developments 11.14 Hamilton 11.14.1 Hamilton Company Information 11.14.2 Hamilton Biobanking Product Offered 11.14.3 Hamilton Biobanking Revenue, Gross Margin and Market Share (2019-2024) 11.14.4 Hamilton Main Business Overview 11.14.5 Hamilton Latest Developments 11.15 So-Low 11.15.1 So-Low Company Information 11.15.2 So-Low Biobanking Product Offered 11.15.3 So-Low Biobanking Revenue, Gross Margin and Market Share (2019-2024) 11.15.4 So-Low Main Business Overview 11.15.5 So-Low Latest Developments 11.16 TTP Labtech Ltd 11.16.1 TTP Labtech Ltd Company Information 11.16.2 TTP Labtech Ltd Biobanking Product Offered 11.16.3 TTP Labtech Ltd Biobanking Revenue, Gross Margin and Market Share (2019-2024) 11.16.4 TTP Labtech Ltd Main Business Overview 11.16.5 TTP Labtech Ltd Latest Developments 11.17 Biolife Solutions 11.17.1 Biolife Solutions Company Information 11.17.2 Biolife Solutions Biobanking Product Offered 11.17.3 Biolife Solutions Biobanking Revenue, Gross Margin and Market Share (2019-2024) 11.17.4 Biolife Solutions Main Business Overview 11.17.5 Biolife Solutions Latest Developments 11.18 DNA Genotek 11.18.1 DNA Genotek Company Information 11.18.2 DNA Genotek Biobanking Product Offered 11.18.3 DNA Genotek Biobanking Revenue, Gross Margin and Market Share (2019-2024) 11.18.4 DNA Genotek Main Business Overview 11.18.5 DNA Genotek Latest Developments 11.19 Custom Biogenic Systems 11.19.1 Custom Biogenic Systems Company Information 11.19.2 Custom Biogenic Systems Biobanking Product Offered 11.19.3 Custom Biogenic Systems Biobanking Revenue, Gross Margin and Market Share (2019-2024) 11.19.4 Custom Biogenic Systems Main Business Overview 11.19.5 Custom Biogenic Systems Latest Developments 11.20 LVL Technologies 11.20.1 LVL Technologies Company Information 11.20.2 LVL Technologies Biobanking Product Offered 11.20.3 LVL Technologies Biobanking Revenue, Gross Margin and Market Share (2019-2024) 11.20.4 LVL Technologies Main Business Overview 11.20.5 LVL Technologies Latest Developments 11.21 BioRep 11.21.1 BioRep Company Information 11.21.2 BioRep Biobanking Product Offered 11.21.3 BioRep Biobanking Revenue, Gross Margin and Market Share (2019-2024) 11.21.4 BioRep Main Business Overview 11.21.5 BioRep Latest Developments 12 Research Findings and Conclusion